4542 |
What is the Next Weapon for CTO PCI? |
Maoto Habara |
Apr. 20. 23 |
4541 |
CTO PCI: The Role of Intravascular Ultrasound |
Dimitrios Karmpaliotis |
Apr. 20. 23 |
4540 |
Retrograde: Tips, Tricks, and Troubleshooting in CTO PCI |
Maoto Habara |
Apr. 20. 23 |
4539 |
Antegrade: Tips, Tricks, and Troubleshooting in CTO PCI |
Maoto Habara |
Apr. 20. 23 |
4538 |
Lifelong Antiplatelet Therapy after PCI for Prevention of Ischemic Events |
Jeehoon Kang |
Apr. 20. 23 |
4537 |
Updated Antiplatelet Approaches for ACS Patients; Tailored DAPT Strategy in De-scalation Era |
Kyung Hoon Cho |
Apr. 20. 23 |
4536 |
What to Know When Treating Your High Risk Elderly Patients |
Jung Ho Heo |
Apr. 20. 23 |
4535 |
What to Know When Treating Your High Risk Women Patients |
Ju Yeol Baek |
Apr. 20. 23 |
4534 |
Ranger DCB: An Essential Choice for Treating Popliteal Artery |
Tae-Hoon Kim |
Apr. 20. 23 |
4533 |
Eluvia : IMPERIAL Trial |
Chul-Min Ahn |
Apr. 20. 23 |